235 related articles for article (PubMed ID: 7861463)
1. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.
Roodi N; Bailey LR; Kao WY; Verrier CS; Yee CJ; Dupont WD; Parl FF
J Natl Cancer Inst; 1995 Mar; 87(6):446-51. PubMed ID: 7861463
[TBL] [Abstract][Full Text] [Related]
2. Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors.
Iwase H; Greenman JM; Barnes DM; Hodgson S; Bobrow L; Mathew CG
Cancer Lett; 1996 Nov; 108(2):179-84. PubMed ID: 8973592
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment.
Caleffi M; Teague MW; Jensen RA; Vnencak-Jones CL; Dupont WD; Parl FF
Cancer; 1994 Apr; 73(8):2147-56. PubMed ID: 8156519
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.
Yaich L; Dupont WD; Cavener DR; Parl FF
Cancer Res; 1992 Jan; 52(1):77-83. PubMed ID: 1345763
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the estrogen receptor-alpha gene in familial ovarian cancer.
Wu HJ; Sekine M; Kashima K; Hirai Y; Hatae M; Kobayashi I; Obata K; Enomoto T; Umesaki N; Ushijima K; Tanaka K;
J Obstet Gynaecol Res; 2005 Oct; 31(5):375-83. PubMed ID: 16176503
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study.
Hsiao WC; Young KC; Lin SL; Lin PW
Breast Cancer Res; 2004; 6(3):R180-6. PubMed ID: 15084241
[TBL] [Abstract][Full Text] [Related]
7. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
8. The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.
Fuqua SA; Allred DC; Elledge RM; Krieg SL; Benedix MG; Nawaz Z; O'Malley BW; Greene GL; McGuire WL
Breast Cancer Res Treat; 1993; 26(2):191-202. PubMed ID: 8219256
[TBL] [Abstract][Full Text] [Related]
9. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor mutations in tamoxifen-resistant breast cancer.
Karnik PS; Kulkarni S; Liu XP; Budd GT; Bukowski RM
Cancer Res; 1994 Jan; 54(2):349-53. PubMed ID: 8275466
[TBL] [Abstract][Full Text] [Related]
11. T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.
Graham ML; Krett NL; Miller LA; Leslie KK; Gordon DF; Wood WM; Wei LL; Horwitz KB
Cancer Res; 1990 Oct; 50(19):6208-17. PubMed ID: 2400987
[TBL] [Abstract][Full Text] [Related]
12. [Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer].
Iwase H; Kobayashi S; Iwata H; Yamashita T; Ito K; Toyama T; Hara Y; Greenman J; Mathew CG
Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():61-5. PubMed ID: 8702313
[TBL] [Abstract][Full Text] [Related]
13. The oestrogen receptor codon 10 polymorphism detected in breast cancer is also present in non-malignant cells.
Moutsatsou P; Fountas L; Coulocheri S; Kassi E; Sekeris CE
J Cancer Res Clin Oncol; 1999; 125(3-4):214-8. PubMed ID: 10235476
[TBL] [Abstract][Full Text] [Related]
14. Incidence of an estrogen receptor polymorphism in breast cancer patients.
Schmutzler RK; Sanchez M; Lehrer S; Chaparro CA; Phillips C; Rabin J; Schachter B
Breast Cancer Res Treat; 1991 Oct; 19(2):111-7. PubMed ID: 1756270
[TBL] [Abstract][Full Text] [Related]
15. Novel mutations in the estrogen receptor messenger RNA in human breast cancers.
Murphy LC; Wang M; Coutt A; Dotzlaw H
J Clin Endocrinol Metab; 1996 Apr; 81(4):1420-7. PubMed ID: 8636345
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
[TBL] [Abstract][Full Text] [Related]
17. Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells.
Koehorst SG; Jacobs HM; Thijssen JH; Blankenstein MA
J Steroid Biochem Mol Biol; 1993 Apr; 45(4):227-33. PubMed ID: 8499331
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors.
Nembrot M; Quintana B; Mordoh J
Biochem Biophys Res Commun; 1990 Jan; 166(2):601-7. PubMed ID: 2302226
[TBL] [Abstract][Full Text] [Related]
19. Role of estrogen receptor variants in the development of hormone resistance in breast cancer.
Sluyser M
Clin Biochem; 1992 Dec; 25(6):407-14. PubMed ID: 1362141
[TBL] [Abstract][Full Text] [Related]
20. Monoallelic amplification of estrogen receptor-alpha expression in breast cancer.
Schuur ER; Weigel RJ
Cancer Res; 2000 May; 60(10):2598-601. PubMed ID: 10825128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
